1 Min Read
July 17 (Reuters) - Basilea Pharmaceutica AG : * Submits Isavuconazole European marketing authorization application for the
treatment of invasive mold infections * Source text for Eikon * Further company coverage
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.